Is remote robotic subretinal injection feasible?
A remote surgeon completed the precision injection without intraoperative complications in a single-case proof-of-concept report.
-
By
-
Andrea Surnit
-
September 2, 2026
-
Clinical Scorecard: Is remote robotic subretinal injection feasible?
At a Glance
| Category | Detail |
|---|
| Condition | Submacular hemorrhage |
| Key Mechanisms | Remote robotic-assisted subretinal injection of recombinant tissue plasminogen activator |
| Target Population | Patients with submacular hemorrhage |
| Care Setting | Ophthalmic surgery |
Key Highlights
- Successful completion of robotic subretinal injection without intraoperative complications
- No serious adverse events during 3 months of follow-up
- Progressive resolution of submacular hemorrhage observed via optical coherence tomography
- Patient reported subjective reduction in central scotoma area
Guideline-Based Recommendations
Diagnosis
- Identify submacular hemorrhage through clinical examination and imaging
Management
- Consider remote robotic subretinal injection following manual pars plana vitrectomy
Monitoring & Follow-up
- Follow-up with optical coherence tomography and visual acuity assessments
Risks
- Potential for irreversible photoreceptor damage with delayed intervention
Patient & Prescribing Data
42-year-old male with sudden central scotoma and vision loss
Robotic injection of 0.056 mL recombinant tissue plasminogen activator
Clinical Best Practices
- Monitor for complications and visual acuity post-procedure
Related Resources & Content
